Reflections on a month in the life of the Ontario Drug Benefit Plan.
作者信息
McIsaac W, Naylor C D, Anderson G M, O'Brien B J
出版信息
CMAJ. 1994 Feb 15;150(4):473-7.
Abstract
摘要
相似文献
1
Reflections on a month in the life of the Ontario Drug Benefit Plan.安大略药品福利计划一个月的生活反思
CMAJ. 1994 Feb 15;150(4):473-7.
2
Should cost-effectiveness take the blame?成本效益该为此负责吗？
CMAJ. 2003 Jun 10;168(12):1528; author reply 1528-9.
3
Inequity in publicly funded physician care: what is the role of private prescription drug insurance?公共资助的医生诊疗服务中的不公平现象：私人处方药保险起到了什么作用？
Health Econ. 2009 Oct;18(10):1218-32. doi: 10.1002/hec.1428.
4
Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative.利用药物流行病学为药物覆盖政策提供信息：两省合作的初步经验教训。
Health Aff (Millwood). 2006 Sep-Oct;25(5):1436-43. doi: 10.1377/hlthaff.25.5.1436.
5
6
[Drug consumption and drug compensation].
Nord Med. 1970 Sep 24;84(39):1249.
7
[Family physicians resist high prescription risk].家庭医生抵制高处方风险。
MMW Fortschr Med. 2003 May 15;145(20):58.
8
Comparative Medicaid drug cost control experiences.
Med Mark Media. 1979 Mar;14(3):38, 40-3.
9
Practitioners and health policy. Case of the Ontario Drug Benefit Plan.从业者与卫生政策。安大略省药物福利计划案例。
Can Fam Physician. 1995 Dec;41:2053-60, 2070-6.
10
Social health insurance and drug spending among cancer inpatients in China.
Health Aff (Millwood). 2008 Jul-Aug;27(4):1020-7. doi: 10.1377/hlthaff.27.4.1020.
引用本文的文献
1
Regional drug information center disseminates educational materials related to the COVID-19 pandemic.地区药品信息中心传播与新冠疫情相关的教育资料。
Explor Res Clin Soc Pharm. 2021 Dec;4:100080. doi: 10.1016/j.rcsop.2021.100080. Epub 2021 Oct 15.
2
Access to medicines: relations with the institutionalization of pharmaceutical services.药品可及性：与药学服务机构化的关系
Rev Saude Publica. 2017 Nov 13;51(suppl 2):8s. doi: 10.11606/S1518-8787.2017051007138.
3
The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives.两害相权取其轻？在全科医疗中开具苯二氮䓬类药物处方：一项关于全科医生观点的定性研究
Scand J Prim Health Care. 2007 Dec;25(4):214-9. doi: 10.1080/02813430701726335.
4
The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach.临床实践中失眠的诊断与管理：一种基于循证的实用方法。
CMAJ. 2000 Jan 25;162(2):216-20.
5
Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.在加拿大将组胺H2受体拮抗剂法莫替丁转为非处方药状态：一项经济学评估。
Pharmacoeconomics. 1996 Jan;9(1):61-75. doi: 10.2165/00019053-199609010-00007.
6
Formulary management of drugs for cancer-associated hypercalcaemia.癌症相关性高钙血症用药的处方集管理
Pharmacoeconomics. 1996 Jan;9(1):39-50. doi: 10.2165/00019053-199609010-00005.
7
Pharmaceutical policies in Canadian family medicine training. Survey of residency programs.加拿大家庭医学培训中的药学政策。住院医师培训项目调查。
Can Fam Physician. 1997 Nov;43:1947-51.
8
Practitioners and health policy. Case of the Ontario Drug Benefit Plan.从业者与卫生政策。安大略省药物福利计划案例。
Can Fam Physician. 1995 Dec;41:2053-60, 2070-6.
9
Variability in prescription drug utilization: issues for research.处方药使用的变异性：研究问题
CMAJ. 1996 Mar 1;154(5):635-40.
本文引用的文献
1
2
Economic and policy analysis of university-based drug "detailing".
Med Care. 1986 Apr;24(4):313-31. doi: 10.1097/00005650-198604000-00003.
3
Psychotropic drug use and the risk of hip fracture.精神药物的使用与髋部骨折风险
N Engl J Med. 1987 Feb 12;316(7):363-9. doi: 10.1056/NEJM198702123160702.
4
Treating hypercholesterolemia. How should practicing physicians interpret the published data for patients?治疗高胆固醇血症。执业医师应如何为患者解读已发表的数据？
N Engl J Med. 1989 Sep 7;321(10):676-80. doi: 10.1056/NEJM198909073211009.
5
Indicative drug budgets for general practitioners: a prescription for change.全科医生的指导性药物预算：变革的良方。
BMJ. 1989 Apr 8;298(6678):944-6. doi: 10.1136/bmj.298.6678.944.
6
Grampian Health Board's joint drug formulary.格兰扁健康委员会联合药品处方集。
BMJ. 1990 Oct 13;301(6756):851-2. doi: 10.1136/bmj.301.6756.851.
7
The Nelson general practice prescribing project. Part I: A pilot audit of the regional prescribing profile.
N Z Med J. 1990 Nov 28;103(902):558-60.
8
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.降低胆固醇水平与死亡率：一级预防试验的定量综述
BMJ. 1990 Aug 11;301(6747):309-14. doi: 10.1136/bmj.301.6747.309.
9
Promoting rational therapeutics: the Swedish guidelines and a UK response.推广合理治疗方法：瑞典指南及英国的回应。
Br J Gen Pract. 1990 Feb;40(331):47-8.
10
PACT and prescribing.精准自适应癌症治疗（PACT）与处方开具
Practitioner. 1991 Feb;235(1499):168-9.
Zotero 插件